Leriva

What Leriva does

Leriva is a privately-held Greek healthcare distribution and marketing enterprise founded in 2009 and headquartered in Melissia, Athens. The company operates through five business units — In Vitro Diagnostics, Life Science & Molecular Diagnostics, Transfusion Technology, Imaging & Contrast Media, and Consumer Health Care — distributing products from global principals including Beckman Coulter (diagnostic instruments and reagents), Bracco (contrast media agents and injectors), Fresenius Kabi (blood bag systems and transfusion devices), and SCIEX (capillary electrophoresis). Leriva also markets proprietary consumer health brands under the Immuvit umbrella (Cardiovit, GranaGard, Flexofytol, Antimetil, Magnevit, BrainUP StressDOWN, No More Lice) through the pharmacy channel, and holds an exclusive collaboration with Panaxia Labs Israel for medical cannabis products under the Panaxir brand in Greece. Operations span Greece, Cyprus, and Albania, supported by a purpose-built distribution center in Aspropyrgos, a regional branch in Thessaloniki, and a technical service facility in Athens.

The company is structured as four legal entities (Leriva S.A., Leriva Diagnostics S.A., Leriva Imaging S.A., Leriva Pharma SA) and employs almost 70 staff. Its customer base spans over 300 public and private hospitals, approximately 400 diagnostic centers, blood banks handling roughly 550,000 annual donations, imaging centers, physician practices, and pharmacies. Go-to-market relies on direct field sales teams organized by business unit, supported by participation in medical conferences, a corporate website, and newsletter communications. Quality management is anchored in ISO 9001:2015 and ISO 13485:2016 certifications.

Leriva generates revenue through the distribution and marketing of medical devices, diagnostic instruments and reagents, contrast media and injection systems, transfusion technology products, and consumer supplements. Pricing is quote-based B2B for institutional sales, with consumer health products sold through the pharmacy channel. The business model is fundamentally a specialty healthcare distribution franchise with proprietary consumer health brand extension, operating without disclosed venture capital or private equity backing and with ownership concentrated among co-founders George Joakimidis (Group CEO) and Alberto Manouach (Company Group Chairman).

Name

Leriva

Legal name

Leriva S.A.

Website

https://leriva.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

101–250 employees

Short description

Leriva is a Greek privately-held healthcare distribution and marketing enterprise that distributes diagnostic instruments, imaging contrast media, transfusion technology, and proprietary consumer health supplements across Greece, Cyprus, and Albania through five business units and exclusive partnerships with global principals.

Ownership category

akta.pro rank

Product category

Healthcare Distribution and Marketing

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industries

Specialty Pharmaceutical Distributors (HLAIAJAB), Plasma-Derived & Blood Products Distributors (HLAIAJAJ), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)

Keywords

• Healthcare product distribution
• In vitro diagnostics
• Contrast media imaging
• Blood transfusion technology
• Consumer health supplements

Headquarters

HQ city

Melíssia

HQ country

Greece

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Healthcare Product Distribution: Distribution and marketing of healthcare products including diagnostic instruments, reagents, contrast media, transfusion technology products, and consumer health supplements through multiple business units
2. Proprietary Consumer Health Products: Sale of proprietary branded supplements under Immuvit brand including Cardiovit, GranaGard, Flexofytol, Antimetil, Magnevit, and BrainUP StressDOWN marketed through pharmacies

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Leriva distributes and markets diagnostic laboratory instruments, life science research tools, blood transfusion products, diagnostic imaging contrast media and injectors, and proprietary consumer health supplements and medical devices in Greece, Cyprus, and Albania. The company serves as the exclusive regional distributor for global manufacturers (Beckman Coulter, Bracco, Fresenius Kabi, SCIEX) while also building its own Immuvit-branded nutritional supplement portfolio and the Panaxir medical cannabis brand.

Product overview

Leriva is a diversified healthcare enterprise distributing and marketing healthcare products through five distinct business units: Diagnostics (offering Clinical Chemistry, Hematology, Immunoassay, Microbiology, Urinalysis, Special Proteins, and Automation systems via Beckman Coulter partnership), Life Science & Molecular Diagnostics (offering Flow Cytometry, Centrifuges, Particle Characterization, Liquid Handlers, and Capillary Electrophoresis via Beckman Coulter and SCIEX partnerships), Transfusion Technology (offering Blood Bag Systems, Filter Systems, In-Line Systems, and Devices via Fresenius Kabi partnership), Imaging & Contrast Media (offering Contrast Media Agents including Iomeron, Iopamiro, Sonovue, Multihance, Prohance, and Contrast Injectors including CT Exprès, EmpowerCTA+, EmpowerMR via Bracco partnership), and Consumer Health Care (marketing dietary supplements primarily under the Immuvit proprietary brand including Cardiovit, GranaGard, Flexofytol, Antimetil, Magnevit, BrainUP, and medical devices including No More Lice and Provacan CBD Oil). The company operates as a distribution and marketing organization rather than a software or technology platform.

Differentiator

Problem solved

Functional benefit

Brands

• Immuvit: Proprietary nutritional supplement and consumer health care brand
• Panaxir
• Cardiovit
• GranaGard
• No More Lice

Products and services

• Diagnostic Laboratory Instruments Beckman Coulter-branded diagnostic instruments used by hospital laboratories, diagnostic centers, and physician practices in Greece, Cyprus, and Albania. The portfolio spans routine clinical chemistry, hematology, immunoassay, microbiology, urinalysis, special proteins testing, and laboratory automation pre- and post-analytical workflows.
• Life Science Research Instruments Life science and molecular diagnostics instruments for biological and chemical research, including flow cytometry, centrifugation, particle characterization, liquid handling, and capillary electrophoresis systems. Targeted at research institutes, pharmaceutical companies, and industrial customers.
• Transfusion Technology Products Blood collection, separation, and processing products for public hospital blood banks, including CompoFlex blood bag systems, leukocyte depletion filters, in-line blood collection systems (CompoSelect), and CompoDock tubing sealing devices. Distributed in Greece through the Fresenius Kabi partnership.
• Contrast Media Agents Imaging contrast agents covering all major diagnostic imaging modalities: Iomeron and Iopamiro (X-Ray/CT), Multihance and Prohance (MRI), and Sonovue (CEUS). Distributed in Greece through the Bracco partnership for use in public/private hospitals, imaging centers, and private practices.
• Contrast Injection Systems Contrast injection systems for CT and MRI imaging procedures, including the syringeless CT Expres, the syringe-based EmpowerCTA+ with extravasation detection, and the hydraulic-powered EmpowerMR (the world's first MR contrast injection system) for 1.5T to 7T scanners. Distributed under the Bracco Injeneering partnership from 2020.
• Immuvit Proprietary Nutritional Supplements Leriva's proprietary nutritional supplement brand sold through pharmacies under the 'Science You Can Trust' positioning, covering cardiovascular (Cardiovit), pomegranate seed oil (GranaGard), joint health turmeric extract (Flexofytol), ginger extract for nausea (Antimetil), Dead Sea magnesium formulations (Magnevit), and phosphatidylserine/phosphatidic acid cognitive blend (BrainUP StressDOWN).
• Cardiovit Cardiovascular wellness supplement containing proprietary Lycored Nutrient Complex (tomato extract) and thiamine, clinically proven in six trials, marketed under the Immuvit brand through Greek pharmacies.
• GranaGard Submicron self-emulsion formulation of Pomegranate Seed Oil containing Punicic Acid for neuroprotection and mitochondrial support, marketed under the Immuvit brand through pharmacies.
• Flexofytol Patented dietary supplement based on bio-optimized turmeric extract supporting flexibility of joints, muscles, and tendons. Developed by Tilman and sold through Greek pharmacies under Leriva's Immuvit brand.
• Antimetil Concentrated standardized ginger extract for combating nausea and vomiting, developed by Tilman and sold through pharmacies under Leriva's Immuvit brand. Marketed for the entire family including pregnant women and children aged 6+.
• Magnevit Premium magnesium-based dietary supplements under Leriva's Immuvit family, including Magnevit Sport and Magnevit Anti Leg Cramps variants formulated with patented magnesium oxide monohydrate from Dead Sea minerals and developed by Naveh Pharma.
• BrainUP StressDOWN Patented cognitive health supplement with phosphatidylserine (PS) and phosphatidic acid (PA) blend developed by Lipogen, designed to improve mental performance, enhance focus, and address stress. Pack of 30 soft gelatin capsules.
• No More Lice Medical Device Class I CE-marked medical device for pesticide-free lice treatment, containing coconut oil, ylang-ylang, and anise. Produced under license and sold through Greek pharmacies.
• Provacan CBD Oil Full spectrum CBD oil with Guaranteed Total Cannabinoid Content, manufactured in the EU from organic hemp extract and distributed through the pharmacy channel.
• Panaxir Medical Cannabis Products Finished medical cannabis products (tablets, suppositories, inhalation products) manufactured under EU-GMP by Panaxia Labs Israel and commercialized by Leriva in Greece under the Panaxir brand, sold by physician prescription for conditions including nausea from anti-neoplastic drugs, neuropathic pain, cancerous pain, and multiple sclerosis spasticity.

Quantifiable outcome

• Serves over 300 public and private hospitals and approximately 400 diagnostic centers
• +1 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

16 partnerships are on record, tiered flagship, core and minor.

• PanaxiaflagshipStrategic or Co-development Partner · 19 May 2021Exclusive collaboration for manufacture, commercialization, and distribution of medical cannabis finished products (tablets, suppositories, inhalation products) under the Panaxir brand in Greece. Panaxia will register and manufacture products complying with EU-GMP standards while Leriva markets, sells, and distributes to patients following doctor's prescription. First sales anticipated in 2022.
• Bracco InjeneeringcoreChannel Partner/ Reseller/ Distributor · 15 November 2019Expansion of Bracco partnership to include contrast injectors (CT Exprès, EmpowerCTA+, EmpowerMR) and associated consumables, effective January 1, 2020.
• Beckman CoultercoreChannel Partner/ Reseller/ DistributorPrimary distribution partner for diagnostic instruments including clinical chemistry, immunoassay, hematology, microbiology, urinalysis, and automation systems. Leriva serves as the exclusive distributor for Beckman Coulter products in Greece.
• BraccocoreChannel Partner/ Reseller/ DistributorExclusive distribution partnership for contrast media agents (Iomeron, Iopamiro, Multihance, Prohance, Sonovue) and contrast injectors (CT Exprès, EmpowerCTA+, EmpowerMR) covering all key diagnostic imaging modalities.
• Fresenius KabicoreChannel Partner/ Reseller/ DistributorDistribution partner for transfusion technology products including blood bags (CompoFlex), filter systems, in-line systems (CompoSelect), and devices (CompoDock).
• SCIEXcoreChannel Partner/ Reseller/ DistributorDistribution partner for capillary electrophoresis instruments including GenomeLab GeXP, PA 800 Plus, P/ACE MDQ Plus, C100HT Biologics Analyzer, and CESI 8000 Plus systems.
• GenscriptminorChannel Partner/ Reseller/ DistributorDistribution partner for life science and molecular diagnostics products.
• IQ ProductsminorChannel Partner/ Reseller/ DistributorDistribution partner for diagnostic products.
• SeegeneminorChannel Partner/ Reseller/ DistributorDistribution partner for molecular diagnostics products.
• AsuragenminorChannel Partner/ Reseller/ DistributorDistribution partner for molecular diagnostics products.
• Fluidic AnalyticsminorChannel Partner/ Reseller/ DistributorDistribution partner for protein analysis instruments.
• Loop GenomicsminorChannel Partner/ Reseller/ DistributorDistribution partner for genomic analysis products.
• AutobiominorChannel Partner/ Reseller/ DistributorDistribution partner for diagnostic products.
• iREPERTOIREminorChannel Partner/ Reseller/ DistributorDistribution partner for immunology and cell analysis products.
• TanbeadminorChannel Partner/ Reseller/ DistributorDistribution partner for molecular diagnostics products.
• GranalixminorChannel Partner/ Reseller/ DistributorDistribution partner for consumer health products.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• ELPEN Pharmaceutical: Greek pharmaceutical manufacturer with broad product portfolio including hospital and consumer health products; directly comparable as a Greek-based healthcare products company serving hospital and pharmacy channels.
• Sarantis Group: Greek consumer health and personal care company selling branded products through pharmacy and retail channels in Greece and Southeast Europe; comparable in Greek consumer health distribution with growing export footprint.
• Lavipharm: Greek pharmaceutical company operating across prescription drugs, OTC, and consumer health; comparable Greek-based pharma company serving the same hospital and pharmacy channels as Leriva.
• Help Pharmaceuticals: Greek pharmaceutical and consumer health company marketing branded products through hospital and pharmacy channels in Greece and broader Balkans; competes with Leriva in the same country and channels.
• Gerolymatos Group: Greek healthcare and consumer products group, predecessor employer of Leriva's founders, operating across pharmaceuticals, diagnostics, and consumer health; directly overlapping with Leriva's diversified Greek healthcare model.

Broad incumbents

• Medline Industries: Large medical supply manufacturer and distributor serving hospitals, surgery centers, and physician offices globally; relevant as a broad healthcare distribution incumbent competing for similar OEM relationships.
• McKesson: Global pharmaceutical and medical products distributor serving hospitals, pharmacies, and healthcare providers; representative of what large-scale healthcare distribution looks like and the benchmark Leriva aspires toward regionally.
• Cardinal Health: Global healthcare products distributor spanning pharmaceutical, medical, and laboratory products; analogous model to Leriva's multi-BU medical products distribution across hospitals and diagnostics.
• Cencora (AmerisourceBergen): Global pharmaceutical distribution and specialty distribution leader; comparable as one of the largest pharmaceutical wholesalers globally, of which Leriva is a small regional analog.
• Henry Schein: Global distributor of medical, dental, and healthcare products to office-based practitioners; comparable distribution model for diagnostic, lab, and medical practice supply.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/LerivaGR
• LinkedInlinkedin.com/company/leriva

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Leriva